TITLE

Phenytoin Tolerance Tests

AUTHOR(S)
Handley, Anthony J.
PUB. DATE
July 1970
SOURCE
British Medical Journal;7/25/1970, Vol. 3 Issue 5716, p203
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
No abstract available.
ACCESSION #
64321610

 

Related Articles

  • Medication problems with flu. Gauthier-Lewis, Mary; Vieira, James A. // Drug Topics;1/20/2003, Vol. 147 Issue 2, pHSE15 

    Discusses how a clinical pharmacist can recommend dosages for phenytoin being taken by a patient for epilepsy who was admitted to a hospital with influenza. Recommendation for a total phenytoin serum concentration, albumin level, pre-albumin level and pregnancy test. Importance of the...

  • Multicentre comparative trial of sodium valproate and phenytoin in elderly patients with newly... Tallis, R; Craig, I // Age & Ageing;May94, Vol. 23 Issue 3, British Geriatrics... pP5 

    Investigates the pharmacologic effects of sodium valproate and phenytoin in elderly patients with elderly-onset epilepsy. Assessment of tolerability; Valproate recipients with failure on randomized treatment; Phenytoin recipients with failure on randomized treatment; Patients who achieved cure...

  • Phenytoini natrici compressi.  // International Pharmacopoeia: Third Edition;2003, p176 

    Description of the phenytoin sodium tablets, which are included in the category of anti-epileptic drugs, is presented. It is noted that the phenytoin sodium tablets are included in the current World Health Organization model list of essential drugs. The identity test and benzophenone test of the...

  • ANTICONVULSANT DRUGS: CARBAMAZEPINE, ETHOSUXIMIDE, PHENOBARBITAL, PHENYTOIN, PRIMIDONE, VALPROIC ACID. Schnell, Zoanne Burgess; Van Leeuwen, Anne M.; Kranpitz, Todd R. // Davis's Comprehensive Handbook of Laboratory & Diagnostic Tests ;Jan2003, p112 

    Presents a comprehensive guide to laboratory and diagnostic tests for anticonvulsant drugs carbamazepine, ethosuximide, phenobarbital, phenytoin, primidone and valproic acid. Specimen collection; Reference value; Indications.

  • PHENYTOIN.  // International Pharmacopoeia: Fourth Edition;2006, Vol. 2, p741 

    A monograph for the pharmaceutical substance "PHENYTOINUM/PHENYTOIN" from the fourth edition of "The International Pharmacopoeia" is presented. Phenytoin is categorized as an anticonvulsant and described as an odourless, white, crystalline powder. It is recommended that this substance be kept in...

  • PHENYTOIN SODIUM.  // International Pharmacopoeia: Fourth Edition;2006, Vol. 2, p743 

    A monograph for the pharmaceutical substance "PHENYTOINUM NATRICUM/PHENYTOIN SODIUM" from the fourth edition of "The International Pharmacopoeia" is presented. Phenytoin sodium is categorized as an anticonvulsant and described as an odourless, white powder. It is recommended that this substance...

  • Motion potion. Gutfeld, Greg; Sangiorgio, Maureen; Rao, Linda // Prevention;Nov91, Vol. 43 Issue 11, p19 

    Reports on a small study of seven Air Force officers who tested a drug that helps quell motion sickness. The officers either took the anticonvulsant phenytoin or a placebo every four hours for 20 hours. Details of the test they went through; Adverse side effects of phenytoin; Phenytoin proved...

  • Fosphenytoin and Phenytoin in Patients with Status Epilepticus: Improved Tolerability versus Increased Costs. deToledo, J.C.; Ramsay, R. // Drug Safety;Jun2000, Vol. 22 Issue 6, p459 

    Tonic-clonic status epilepticus (TCSE) is the most common neurological emergency and affects approximately 60 000 patients each year in the US. The risk of complications increases substantially as TCSE lasts longer than 60 minutes. Ideally, drugs used to treat this condition should be well...

  • Phenytoin-induced Hypothermia in a Patient with Mental Retardation. Soghoian, S.; Heinis, C. G.; Su, M. // Internet Journal of Neurology;2008, Vol. 10 Issue 1, p8 

    Background: Phenytoin toxicity presenting as hypothermia has been reported in patients with mental retardation (MR), without causative explanation. We report a case in a patient with adrenal insufficiency. Case Report: A 50-year-old man with a history of MR and seizures was found lethargic....

  • Fosphenytoin: clinical pharmacokinetics and comparative advantages in the acute treatment of seizures. Fischer, J.H.; Patel, T.V.; Fischer, P.A.; Fischer, James H; Patel, Tejal V; Fischer, Patricia A // Clinical Pharmacokinetics;Jan2003, Vol. 42 Issue 1, p33 

    Fosphenytoin is a phosphate ester prodrug developed as an alternative to intravenous phenytoin for acute treatment of seizures. Advantages include more convenient and rapid intravenous administration, availability for intramuscular injection, and low potential for adverse local reactions at...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics